Survival rate in hypertensive patients with COVID-19

Associations of hypertension with the severity and fatality of SARS-CoV-2 infection: A meta-analysis

(2020) Jingqi Zhang et al.   EPIDEMIOLOGY AND INFECTION

Potential differential effects of renin-angiotensin system inhibitors on SARS-CoV-2 infection and lung injury in COVID-19

(2020) Masato Furuhashi et al.   HYPERTENSION RESEARCH

COVID-19: Social distancing, ACE 2 receptors, protease inhibitors and beyond?

(2020) George Thomson   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

The SARS-CoV-2 outbreak: What we know

(2020) Di Wu et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Managing hypertension during the COVID-19 pandemic

(2020) Sunil K. Nadar et al.   JOURNAL OF HUMAN HYPERTENSION

ACE2 receptor polymorphism: Susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome

(2020) Christian A. Devaux et al.   JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION

Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?

(2020) Lei Fang et al.   Lancet Respiratory Medicine

COVID-19, hypertension and cardiovascular diseases: Should we change the therapy?

(2020) Marijana Tadic et al.   PHARMACOLOGICAL RESEARCH

Comparison of confirmed COVID ‐19 with SARS and MERS cases ‐ Clinical characteristics, laboratory findings, radiographic signs and outcomes: A systematic review and meta‐analysis

(2020) Ali Pormohammad et al.   REVIEWS IN MEDICAL VIROLOGY